Les Laboratoires des Médicaments Stériles   Report issue

For profit Phase 4
Founded: Tunis Tunisia (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2010
NCT01431495
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Les Laboratoires des Médicaments Stériles | mohamed bouchoucha

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Cardiovascular Diseases (Phase 4)

Coronary Disease (Phase 4)

Digestive System Neoplasms (Phase 4)

Gastrointestinal Neoplasms (Phase 4)

Overweight (Phase 4)

Placental Insufficiency (Phase 4)

Syndrome (Phase 4)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 7